Friday, September 29, 2023


Biotechnology News Magazine

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

Latest Posts

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics began recruiting patients on March 28, 2023, for daily treatment up to 7 days at the highest dose of zelpultide alfa (rhSP-D) following a Data Safety Monitoring Committee (DSMC) report of no safety concerns.

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights to help improve care decisions.

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis.

MGCLF – MGC Pharma’s CannEpil® Now Accessible to UK Patients on Named Patient Request Basis

European pharmaceutical company offers its investigational medicinal product to a wide range of specialist medical practitioners in the United Kingdom Epidiolex's Success Highlights Potential for MGC Pharma's CannEpil®.

PathO3Gen Solutions multi-patented UVZone® shoe sanitizing technology is proven to eliminate Candida auris up to 99.9993% in 10 seconds.

A study published by Infection Control and Hospital Epidemiology proves pathogens spread from floors to high-touch surfaces. A systematic review in the Journal of Applied Microbiology presents a number of studies identifying shoes and floors as a potential vector for pathogen transmission.

PathO3Gen Solutions’ multi-patented UVZone Shoe Sanitizing Stations, when placed in high-traffic and high-risk areas, enhance healthcare facility infection control measures, and may improve overall hospital biosafety.

The UVZone multi-patented combination of UV-C and ozone is proven 99.9993% effective — 5.16 Log in 10 seconds and 99.9974% -4.58 Log in 8 seconds against Candida auris. The unit activates a controlled release of short-wave ultraviolet light (known as UVC) through a window of Corning® HPFS® Fused Silica(High Purity Fused Silica), transmitting the intense UV-C rays with virtually no attenuation, essential to effectiveness of the footpad, which is large enough to cover shoe soles.

Proven efficacy includes reductions up to 99.9960% for C. diff, 99.9969% for MRSA, 99.9986% for K. pneumoniae, 99.9989% for E. coli.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine